Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

BACKGROUND: The addition of bevacizumab to chemotherapy improved outcomes for patients with metastatic colon cancer. E5204 was designed to test whether the addition of bevacizumab to mFOLFOX6, following neoadjuvant chemoradiation and definitive surgery, could improve overall survival (OS) in patient...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncologist
المؤلفون الرئيسيون: Chakravarthy, A. Bapsi, Zhao, Fengmin, Meropol, Neal J., Flynn, Patrick J., Wagner, Lynne I., Sloan, Jeffrey, Diasio, Robert B., Mitchell, Edith P., Catalano, Paul, Giantonio, Bruce J., Catalano, Robert B., Haller, Daniel G., Awan, Rashid A., Mulcahy, Mary F., O'Brien, Timothy E., Santala, Roger, Cripps, Christine, Weis, John R., Atkins, James N., Leichman, Cynthia G., Petrelli, Nicholas J., Sinicrope, Frank A., Brierley, James D., Tepper, Joel E., O'Dwyer, Peter J., Sigurdson, Elin R., Hamilton, Stanley R., Cella, David, Benson, Al B.
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley & Sons, Inc. 2019
الموضوعات:
Gastrointestinal Cancer
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216434/
https://ncbi.nlm.nih.gov/pubmed/31852811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0437
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة